738 related articles for article (PubMed ID: 19274516)
1. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
[TBL] [Abstract][Full Text] [Related]
2. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Hakala M; Korpela M; Ilva K; Yli-Kerttula U; Piirainen H; Leirisalo-Repo M;
Ann Rheum Dis; 2005 Jan; 64(1):130-3. PubMed ID: 15608311
[TBL] [Abstract][Full Text] [Related]
3. Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Pohjolainen T; Korpela M; Vuori K; Ilva K; Yli-Kerttula U; Järvinen P; Leirisalo-Repo M
Scand J Rheumatol; 2007; 36(4):270-7. PubMed ID: 17763204
[TBL] [Abstract][Full Text] [Related]
4. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
5. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Hakala M; Järvinen P; Ahonen J; Forsberg S; Leirisalo-Repo M;
Arthritis Rheum; 2005 Jan; 52(1):36-41. PubMed ID: 15641055
[TBL] [Abstract][Full Text] [Related]
6. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
7. Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity.
Verstappen SM; Boonen A; Verkleij H; Bijlsma JW; Buskens E; Jacobs JW;
Ann Rheum Dis; 2005 Dec; 64(12):1754-60. PubMed ID: 15860510
[TBL] [Abstract][Full Text] [Related]
8. The methotrexate therapeutic response in rheumatoid arthritis.
Ortendahl M; Holmes T; Schettler JD; Fries JF
J Rheumatol; 2002 Oct; 29(10):2084-91. PubMed ID: 12375316
[TBL] [Abstract][Full Text] [Related]
9. Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
Wolfe F; Michaud K; Choi HK; Williams R
J Rheumatol; 2005 Oct; 32(10):1875-83. PubMed ID: 16206340
[TBL] [Abstract][Full Text] [Related]
10. Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability.
Baumgartner SW; Fleischmann RM; Moreland LW; Schiff MH; Markenson J; Whitmore JB
J Rheumatol; 2004 Aug; 31(8):1532-7. PubMed ID: 15290731
[TBL] [Abstract][Full Text] [Related]
11. Work limitations among working persons with rheumatoid arthritis: results, reliability, and validity of the work limitations questionnaire in 836 patients.
Walker N; Michaud K; Wolfe F
J Rheumatol; 2005 Jun; 32(6):1006-12. PubMed ID: 15940759
[TBL] [Abstract][Full Text] [Related]
12. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
Welsing PM; Fransen J; van Riel PL
Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis is already expensive during the first year of the disease (the Swedish TIRA project).
Hallert E; Husberg M; Jonsson D; Skogh T
Rheumatology (Oxford); 2004 Nov; 43(11):1374-82. PubMed ID: 15280570
[TBL] [Abstract][Full Text] [Related]
14. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
Clarke AE; St-Pierre Y; Joseph L; Penrod J; Sibley JT; Haga M; Genant HK
J Rheumatol; 2001 Nov; 28(11):2416-24. PubMed ID: 11708412
[TBL] [Abstract][Full Text] [Related]
15. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.
Sokka T; Kautiainen H; Hannonen P; Pincus T
Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231
[TBL] [Abstract][Full Text] [Related]
16. Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials.
Smolen JS; Aletaha D; Grisar JC; Stamm TA; Sharp JT
Ann Rheum Dis; 2010 Jun; 69(6):1058-64. PubMed ID: 19717399
[TBL] [Abstract][Full Text] [Related]
17. Work disability in rheumatoid arthritis--development over 15 years and evaluation of predictive factors over time.
Eberhardt K; Larsson BM; Nived K; Lindqvist E
J Rheumatol; 2007 Mar; 34(3):481-7. PubMed ID: 17299844
[TBL] [Abstract][Full Text] [Related]
18. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial.
Kobelt G; Lindgren P; Singh A; Klareskog L
Ann Rheum Dis; 2005 Aug; 64(8):1174-9. PubMed ID: 15708879
[TBL] [Abstract][Full Text] [Related]
20. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.
Kobelt G; Lindgren P; Lindroth Y; Jacobson L; Eberhardt K
Rheumatology (Oxford); 2005 Sep; 44(9):1169-75. PubMed ID: 15956093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
